AI assistant
Sending…
RESMED INC — Director's Dealing 2017
Nov 14, 2017
30071_dirs_2017-11-14_b6a19709-8484-48c1-8e64-e58a1b9df994.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-10
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-10 | ResMed Common Stock | F | 5680 | $83.06 | Disposed | 60098 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 6309 | $83.06 | Disposed | 53789 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 91368 | Indirect |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.
F2: Includes 177 shares of ResMed stock purchased on October 31, 2017, through the ResMed Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29